Medicare Enrolled
Dr. Paul La Porte, M.D., PH.D.
Internal Medicine · Cerritos, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. La Porte from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. La Porte?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. La Porte
Dr. Paul La Porte is an internal medicine specialist in Cerritos, CA, with 13 years of NPI registration. Based on federal Medicare data, Dr. La Porte performed 9,689 Medicare services across 964 unique beneficiaries.
Between the years covered by Open Payments, Dr. La Porte received a total of $8,067 from 69 pharmaceutical and/or device companies across 357 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. La Porte is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 13 years in practice
▲ Top 2% volume in CA
$8,067 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,689
Medicare services
Top 2% in CA for internal medicine
964
Unique beneficiaries
$24
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~745 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,090 | $0 | $5 |
| Injection, leucovorin calcium, per 50 mg | 1,387 | $3 | $12 |
| Injection, granisetron hydrochloride, 100 mcg | 1,130 | $0 | $2 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
1,092 | $76 | $550 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
875 | $2 | $6 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
327 | $8 | $27 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
318 | $10 | $37 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
237 | $123 | $540 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
193 | $106 | $385 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
178 | $144 | $540 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
175 | $14 | $73 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
145 | $26 | $117 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
143 | $26 | $103 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
143 | $61 | $263 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
132 | $75 | $275 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
125 | $13 | $71 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
108 | $159 | $588 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
94 | $8 | $17 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
86 | $19 | $66 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
86 | $18 | $68 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
78 | $2 | $25 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
67 | $12 | $51 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
67 | $47 | $187 |
| On-body injector for subcutaneous injection A device is applied to the skin to automatically deliver a medication injection under the skin. |
42 | $17 | $76 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
41 | $1 | $5 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
40 | $42 | $139 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
38 | $22 | $92 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
38 | $1 | $3 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
24 | $13 | $48 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
23 | $5 | $17 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
22 | $6 | $21 |
| Iron level test | 21 | $6 | $23 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
21 | $60 | $225 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
20 | $4 | $16 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
20 | $28 | $106 |
| Glutamyltransferase (GGT) level test A blood test that measures the level of the liver enzyme glutamyltransferase (GGT) to help evaluate liver health. |
18 | $7 | $25 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
17 | $9 | $26 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
17 | $16 | $59 |
| New patient office visit, complex (60-74 min) | 11 | $147 | $594 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
7.3% high complexity
74.4% medium
18.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,067
Total received (2018-2024)
Avg $1,152/year across 7 years
Top 12% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
69
Companies
357
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,873 (97.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$195 (2.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$672
2023
$1,674
2022
$1,801
2021
$1,744
2020
$1,319
2019
$714
2018
$142
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$79
SpringWorks Therapeutics, Inc.
$78
Janssen Biotech, Inc.
$70
Apellis Pharmaceuticals, Inc.
$61
Celgene Corporation
$55
Takeda Pharmaceuticals U.S.A., Inc.
$53
Novartis Pharmaceuticals Corporation
$53
AstraZeneca Pharmaceuticals LP
$47
Daiichi Sankyo Inc.
$43
Ipsen Biopharmaceuticals, Inc
$30
Eisai Inc.
$30
SOBI, INC
$22
Tempus AI, Inc
$20
PFIZER INC.
$17
Astellas Pharma US Inc
$15
Top 3 companies account for 33.8% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$864
E.R. Squibb & Sons, L.L.C.
$506
Novartis Pharmaceuticals Corporation
$500
Alexion Pharmaceuticals, Inc.
$451
AstraZeneca Pharmaceuticals LP
$407
Janssen Biotech, Inc.
$337
Incyte Corporation
$327
Celgene Corporation
$327
Lilly USA, LLC
$312
Seagen Inc.
$286
GE HealthCare
$257
Karyopharm Therapeutics Inc.
$221
Boehringer Ingelheim Pharmaceuticals, Inc.
$202
GlaxoSmithKline, LLC.
$187
Takeda Pharmaceuticals U.S.A., Inc.
$167
Merck Sharp & Dohme Corporation
$157
Astellas Pharma US Inc
$149
GENZYME CORPORATION
$121
Ipsen Biopharmaceuticals, Inc
$110
Eisai Inc.
$109
Daiichi Sankyo Inc.
$109
Bayer HealthCare Pharmaceuticals Inc.
$104
Exelixis Inc.
$101
Amgen Inc.
$99
Kite Pharma, Inc.
$93
ABBVIE INC.
$86
SpringWorks Therapeutics, Inc.
$78
Pharmacyclics LLC, An AbbVie Company
$76
Blueprint Medicines Corporation
$76
Clovis Oncology, Inc.
$69
EISAI INC.
$67
EMD Serono, Inc.
$62
Apellis Pharmaceuticals, Inc.
$61
Gilead Sciences, Inc.
$51
Stemline Therapeutics Inc.
$49
Taiho Oncology, Inc.
$47
ARRAY BIOPHARMA INC
$46
Rigel Pharmaceuticals, Inc.
$45
Regeneron Pharmaceuticals, Inc.
$40
ImmunoGen, Inc.
$36
GE HEALTHCARE
$34
TAIHO ONCOLOGY, INC.
$30
Merck Sharp & Dohme LLC
$30
Adaptive Biotechnologies Corporation
$29
Janssen Scientific Affairs, LLC
$29
TESARO, Inc.
$29
Genmab U.S., Inc.
$28
Mirati Therapeutics, Inc.
$27
Verastem, Inc.
$25
Teva Pharmaceuticals USA, Inc.
$25
Sun Pharmaceutical Industries Inc.
$25
AMAG Pharmaceuticals, Inc.
$24
PharmaEssentia USA Corporation
$23
Blue Earth Diagnostics Limited
$23
TOLMAR Pharmaceuticals, Inc.
$23
Seattle Genetics, Inc.
$22
Array BioPharma Inc.
$22
Foundation Medicine, Inc.
$22
SOBI, INC
$22
TerSera Therapeutics LLC
$21
Puma Biotechnology, Inc.
$21
CTI BioPharma Corp.
$21
Tempus AI, Inc
$20
G1 Therapeutics, Inc.
$20
Global Blood Therapeutics, Inc.
$17
EUSA Pharma (US) LLC
$17
Myriad Genetic Laboratories, Inc.
$16
Genentech USA, Inc.
$16
Sirtex Medical Inc
$16
Top 3 companies account for 23.2% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · AYVAKIT · Axumin · BAVENCIO · BENDEKA · BESREMI · BOSULIF · BRAFTOVI · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CERDELGA · COSELA · CYRAMZA · Cabometyx · Copiktra · DARZALEX · ELIGARD · ENHERTU · ENJAYMO · ERLEADA · Elahere · Empaveli · Enhertu · Epkinly · FERAHEME · FRUZAQLA · GAVRETO · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INLYTA · INQOVI · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · NINLARO · Nerlynx · Nplate · Nubeqa · OGSIVEO · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · POLIVY · PROMACTA · Padcev · Pomalyst · REBLOZYL · RYBREVANT · Revlimid · Rubraca · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SYNAGIS · Stivarga · Sylvant · TALZENNA · TUKYSA · Tavalisse · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · Vonjo · XALKORI · XOSPATA · XPOVIO · XT CDX · XTANDI · Xospata · YONSA · ZEJULA · Zoladex · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Internal medicine physicians within 10 mi
4,795
Per 100K population
48.7
County median income
$87,760
Nearest hospital
COLLEGE HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. La Porte is a mixed practice specialist, with above-average Medicare volume (top 2% in CA), with low-engagement industry engagement in the top 12% of CA peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. La Porte experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. La Porte performed 2,090 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. La Porte receive payments from pharmaceutical companies?
Yes. Dr. La Porte received a total of $8,067 from 69 companies across 357 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. La Porte's costs compare to other internal medicine physicians in Cerritos?
Dr. La Porte's average Medicare payment per service is $24. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. La Porte) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Cerritos
Browse internal medicine physicians in Cerritos ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in CA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in CA
Which CA internal medicine physicians receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology